Monoclonal antibodies to CD4

Rheumatic Disease Clinics of North America

Volumn 24, Issue 3, 1998, Pages 567-578

  Breedveld, F C ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; COLLAGEN; MONOCLONAL ANTIBODY;

ARTHRITIS; AUTOIMMUNE DISEASE; IMMUNOLOGICAL TOLERANCE; IMMUNOTHERAPY; PRIORITY JOURNAL; REVIEW;

EID: 0031717315     PISSN: 0889857X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-857X(05)70026-0     Document Type: Article

References (63)

1. M. Bartholomew S. Brett K. Barber Functional analysis of the effects of a fully humanized anti-CD4 mAb on resting and activated human T cells Immunology 85 1995 41
2. M.E. Billingham C.A. Hicks S.L. Corney Monoclonal antibodies and arthritis Agents Actions 29 1990 77
3. m-labelled polyclonal human immunoglobulin G scintigraphy before and after intra-articular knee injection of triamcinolone hexacetonide in patients with rheumatoid arthritis Nucl Med Commun 14 1993 883
4. S.W. Brostoff D.W. Mason Experimental allergic encephalomyelitis: Successful treatment in vivo with a monoclonal antibody that recognizes T helper cells J Immunol 133 1984 1938
5. G.R. Burmester B. Stuhmüller G. Keyser Mononuclear phagocytes and rheumatoid synovitis: Mastermind or workhorse in arthritis Arthritis Rheum 40 1997 5
6. N.L. Carteron C.L. Schimenti D. Wofsy Treatment of murine lupus with F(Ab′)2 fragments of monoclonal antibody to L3T4 J Immunol 142 1989 1470
7. E.H.S. Choy I.C. Chikanza G.H. Kingsley Treatment of rheumatoid arthritis with single dose or weekly pulses of chimaeric anti-CD4 monoclonal antibody Scand J Immunol 36 1992 291
8. E.H.S. Choy C. Pitzales J.A. Bijl Percentage of anti-CD4 monoclonal antibody-coated lymphocytes in the rheumatoid joint is associated with clinical improvement. Implications for the development of immunotherapeutic dosing regimens Arthritis Rheum 39 1996 52
9. E.H.S. Choy D.J.A. Connolly N. Rapson Effect of a humanised non-depleting anti-CD4 monoclonal antibody (mAb) on synovial fluid (SF) in rheumatoid arthritis (RA) Arthritis Rheum 40 suppl 1997 52
10. S.P. Cobbold A. Jayasuria A. Nash Therapy with monoclonal antibodies by elimination of T-cell subsets in vivo Nature 312 1984 548
11. D.R. DeSilva K.B. Urdahl M.K. Jenkins Clonal anergy in induced in vitro by T cell receptor occupancy in the absence of proliferation J Immunol 147 1991 3261
12. C. Doyle J.L. Strominger Interaction between CD4 and class II MHC molecular mediated cell adhesion Nature 330 1987 256
13. E.H. Field T.M. Rouse A.Z. Flemming Altered IFNγ and IL-4 pattern lymphokine secretion in mice partially depleted of CD4 T cells by anti-CD4 monoclonal antibody J Immunol 149 1992 1131
14. G.S. Firestein Invasive fibroblast-like synoviocytes in rheumatoid arthritis: Passive responders or transformed aggressors Arthritis Rheum 39 1996 1781
15. D.A. Fox The role of T cells in the immunopathogenesis of rheumatoid arthritis Arthritis Rheum 540 1997 598
16. 1CK with CD4 in antigen-specific signal transduction in T cells Cell 64 1991 511
17. P.K. Gregersen J. Silver R.J. Winchester The shared epitope hypothesis: An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis Arthritis Rheum 30 1987 1205
18. D.A. Halfer J. Ritz S.F. Schlossman Anti-CD4 anti-CD2 monoclonal antibody infusions in subjects with multiple sclerosis. Immunosuppressive effects and human anti-mouse responses J Immunol 141 1988 131
19. R. Holmdahl L. Klareskog K. Rubin T-lymphocytes in collagen II-specific T-cell lines and clones. Characterization of arthritogenic collage II-specific T-cell lines and clones Scand J Immunol 22 1985 295
20. G. Horneff G.R. Burmester F. Emmerich Treatment of rheumatoid arthritis with an anti-CD4 monoclonal antibody Arthritis Rheum 34 1991 129
21. G. Horneff U. Dirksen H. Schulze-Koops Treatment of refractory juvenile chronic arthritis by monoclonal CD4 antibodies: A pilot study in two children Ann Rheum Dis 54 1995 846
22. P.R. Hutchings L. O'Reilly N.M. Parish The use of a non-depleting anti-CD4 monoclonal antibody to reestablish tolerance to β cells in NOD mice Eur J Immunol 22 1992 1913
23. I. Jamali E.H. Field A. Fleming Kinetics of anti-CD4-induced T helper cell depletion and inhibition of function: Activation by the CD3 pathway inhibits anti-CD4-mediated T cell elimination and down regulation of cell surface CD4 J Immunol 148 1992 1613
24. B. Kakavand C. Reiter E. Rieber Therapeutische CD4-T Zelldepletion mit Hilfe chimärischer, monoklonaler CD4-Antikörper zur Therapie der autoimmunen, chronischen Hepatitis. Klin Wochenschrift 69 Suppl XXVIII 1992 51
25. R.W. Kinne W. Becker G. Simon Joint uptake and distribution of a technetium-99m-labeled anti-rat CD4 monoclonal antibody in rat adjuvant arthritis J Nucl Med 34 1993 92
26. R. Konig L.Y. Huang R.N. Germain Identification of the CD4 binding site of the β2 domain of HLA-DR molecules Nature 356 1992 796
27. R. Levy M. Weisman C. Wiesenhutter Results of a placebo-controlled multicenter trial using a primatized® non-depleting, anti-CD4 monoclonal antibody in the treatment of rheumatoid arthritis Arthritis Rheum 39 suppl 1996 122
28. A.F. Lobuglio R.H. Wheeler J. Trang Mouse/human chimeric monoclonal antibody in man: Kinetics and immune response Proc Natl Acad Sci USA 86 1989 4220
29. R.N. Maini F.C. Breedveld J.R. Kalden Low dose methotrexate (MTX) supresses anti-globulin responses and potentiates efficacy of a chimeric monoclonal anti-TNFα antibody (cA2) given repeatedly in rheumatoid arthritis (RA) Arthritis Rheum 40 suppl 1997 126
30. P.W. Mathieson S.P. Cobbold G. Hale Monoclonal antibody therapy in systemic vasculitis N Engl J Med 323 1990 250
31. L.W. Moreland P.W. Pratt R.P. Bucy Treatment of refractory rheumatoid arthritis with a chimeric anti-CD4 monoclonal antibody. Long-term follow-up of CD4+ T cell counts Arthritis Rheum 37 1994 834
32. L.W. Moreland P.W. Pratt M.D. Mayes Double-blind, placebo-controlled multicenter trial using chimeric monoclonal antibody, cM-T412, in rheumatoid arthritis patients receiving concomitant methotrexate Arthritis Rheum 38 1995 1581
33. L.W. Moreland P.R. Bucy B. Jackson Long-term (5 years) follow-up of rheumatoid arthritis patients treated with a depleting anti-CD4 monoclonal antibody, cM-T412 Arthritis Rheum 39 suppl 1996 244
34. L.W. Moreland R.P. Bucy A. Tilden Use of a chimeric monoclonal anti-CD4 antibody in patients with refractory rheumatoid arthritis Arthritis Rheum 36 1993 307
35. A.W. Morgan G. Hale P. Rebello Combination therapy with a TNF antagonist and a CD4 monoclonal antibody in rheumatoid arthritis. A pilot study Arthritis Rheum 40 suppl 1997 81
36. P. Nickerson W. Steurer J. Steiger Cytokines and the Th1/Th2 paradigm in transplantation Curr Opin Immunol 6 1994 757
37. J.F. Nicolas N. Chamchick J. Thivolet CD4 antibody treatment for severe psoriasis Lancet 338 1991 321
38. G.S. Panayi E.H.S. Choy D.J.A. Connolly T cell hypothesis in rheumatoid arthritis (RA) tested by humanized non-depleting anti-CD4 monoclonal antibody (mAb) treatment I: Suppression of disease activity and acute phase response Arthritis Rheum 39 suppl 1996 244
39. J. Prinz O. Braun-Falco M. Meurer Chimaeric CD4 monoclonal antibody in treatment of generalised pustular psoriasis Lancet 388 1991 320
40. J.C. Prinz M. Meurer C. Reiter Treatment of severe cutaneous lupus erythematosus with a chimeric CD4 monoclonal antibody, cM-T412 J Am Acad Dermatol 34 1996 244
41. S. Qin S.P. Cobbold H. Pope Infectious transplantation tolerance Science 259 1993 974
42. S.A. Radema A. Stronkhorst H. Bijl Anti-CD4 therapy decreases epithelial expression of HLA-DR molecules in patients with Crohn's disease Inflamm Bowel Dis 1 1995 193
43. G. Ranges S. Sriram S.M. Cooper Prevention of type II collage: An experimental model of arthritis J Exp Med 162 1985 1105
44. C. Reiter G.R. Burmester E.P. Rieber Treatment of rheumatoid arthritis with monoclonal CD4 antibody M-T151 Arthritis Rheum 34 1991 525
45. G. Riethmüller E.P. Rieber S. Kiefersauer From antilymphocyte serum to therapeutic monoclonal antibodies: First experiences with a chimeric CD4 antibody in the treatment of autoimmune disease Immunol Rev 129 1992 81
46. H. Schulze-Koops L.S. Davis P. Haverty Reduction of Th1 cell activity in patients with rheumatoid arthritis after treatment with a non-depleting monoclonal antibody to CD4 Arthritis Rheum 40 suppl 1997 191
47. J.A. Shizuru K.B. Seydel T.F. Flavin Induction of donor-specific unresponsiveness to cardiac allografts in rats by pretransplant anti-CD4 monoclonal antibody therapy Transplantation 50 1990 366
48. P. Stumbles D. Mason Activation of CD4+ T cells in the presence of a non-depleting monoclonal antibody to CD4 induces a TH2 type response J Exp Med 182 1995 5
49. P.P. Tak R.Q. Hintzen J.M.J. Teunissen Expression of the activation antigen CD27 in rheumatoid arthritis Clin Immunol Immunopathol 80 1996 129
50. Tak P.P. van der Lubbe P.A. A. Cauli Reduction of synovial inflammation after anti-CD4 monoclonal antibody treatment in early rheumatoid arthritis Arthritis Rheum 38 1995 1457
51. J.R.P. Tesser C. Wiesenhutter R. Levy Treatment of rheumatoid arthritis with a primatized anti-CD4 monoclonal antibody, SB-210396 (IDEC-CE9.1)—Results of an open label extension study in patients responding to induction therapy Arthritis Rheum 40 suppl 1997 224
52. A. Truneh B. MacDonald M. Elliot Treatment of rheumatoid arthritis with a primatized anti-CD4 monoclonal antibody, SB-210396 (IDEC-CE9.1)—Responsiveness correlates with duration of monoclonal antibody coating, CD4 receptor modulation and decrease in number of activated lymphocyte subpopulations Arthritis Rheum 40 suppl 1997 191
53. D.S. Ucher L.D. Helshi J.F. Blomquist Physiological T-cell death Immunol Rev 142 1994 273
54. Van der Lubbe P.A. C. Reiter F.C. Breedveld Chimeric CD4 monoclonal antibody cM-T412 as a therapeutic approach to rheumatoid arthritis Arthritis Rheum 36 1993 1375
55. Van der Lubbe P. A.M. Miltenburg F.C. Breedveld Anti-CD4 monoclonal antibody for relapsing polychondritis Lancet 337 1991 1349
56. Van der Lubbe P.A. C. Reiter A.M. Miltenburg Treatment of rheumatoid arthritis with a chimeric CD4 monoclonal antibody (cM-T412): immunopharmacological aspects and mechanisms of action Scand J Immunol 39 1994 286
57. Van der Lubbe P.A. B.A.C. Dijkmans H.M. Markusse A randomized double-blind placebo-controlled study of CD4 monoclonal antibody therapy in early rheumatoid arthritis Arthritis Rheum 38 1995 1097
58. Van der Lubbe P.A. F.C. Breedveld P.P. Tak Treatment with a chimeric CD4 monoclonal antibody is associated with a relative loss of CD4+/CD45RA+ cells in patients with rheumatoid arthritis J Autoimmun 10 1997 87
59. Van Zeben D. J.M.W. Hazes A.H. Zwinderman Association of HLA-DR4 with a more progressive disease course in patients with rheumatoid arthritis Arthritis Rheum 34 1991 822
60. H. Waldman Manipulation of T cell responses with monoclonal antibodies Annu Rev Immunol 7 1989 407
61. R.O. Williams J. Ghrayeb M. Feldman Successful therapy of collagen-induced arthritis with TNF-receptor-Ig fusion protein and combination with anti-CD4 Immunology 84 1995 433
62. D. Wolfsy W.E. Seaman Reversal of advanced murine lupus in N2B/N2WF1 mice by treatment with monoclonal antibody to L3T4 J Immunol 138 1987 3247
63. A. Weiss D.R. Littman Signal transduction by lymphocyte antigen receptors Cell 76 1994 263